COVID-19 Impact on Steris Plc’s Revenue and Operations (Medical Devices)

COVID-19 Impact on Steris Plc’s Revenue and Operations (Medical Devices)

  • May 2020 •
  • 11 pages •
  • Report ID: 5930841 •
  • Format: PDF
COVID-19 Impact on Steris Plc’s Revenue and Operations (Medical Devices)

Summary
Steris Plc is a medical technology company which designs, develops, manufactures and markets a wide range of medical devices, headquartered in United Kingdom with global manufacturing and sales reach.Steris Plc’s product range include the sterilizers that eliminates living organisms, such as bacteria, fungi, viruses, and spores; surgical equipment and image management that includes OR integration systems, Surgical tables and lights; perioperative solutions, endoscopy accessories and barrier solutions.

It also provides detergents and skin care products, laboratory testing, linen management and off-site reprocessing, microbial reduction of medical devices, and chemical and biological decontamination technologies for aircraft, buildings, vehicles, and sensitive equipment. The report, COVID-19 Impact on Steris Plc’s Revenue and Operations (Medical Devices) presents a deep dive analysis into how Steris Plc is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Steris Plc is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Key Highlights
- The medical equipment manufacturing sector will be the most adversely affected industry during COVID-19 crisis due to delay and cancellation of elective orthopaedic and general surgeries.
- Delay in surgeries have caused severe interruptions in supply chains of American and European markets. This is going to create an adverse effect on the revenues at the end of 2020. However, Steris might be able to maintain a steady revenue due to its expertise in sterilization and decontamination equipment which will be very useful during the COVID-19 outbreak.
- The business units are affected by delays and interruptions in supply chains. The company’s consolidated financial results are expected to be impacted in a continue manner because of the spread of infection in the upcoming quarters.

Scope
The report provides a comprehensive analysis of the impact of COVID-19 on Steris Plc -
- It provides insights on Steris Plc’s exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Reasons to Buy
- An overview of how Steris Plc will be affected by the COVID-19 pandemic.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.